The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Infanrix hexa

GlaxoSmithKline Biologicals S.A.EU/1/00/152/002

Main Information

Trade NameInfanrix hexa
Active SubstancesHaemophilus influenzae
Hbs ag
Tetanus toxoid
Pertussis toxoid
Filamentous haemagglutinin (fha)
Diphtheria toxoid
Dosage FormPowder and suspension for suspension for injection
Licence HolderGlaxoSmithKline Biologicals S.A.
Licence NumberEU/1/00/152/002

Group Information

ATC CodeJ07CA Bacterial and viral vaccines, combined


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back